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Background: Schizophrenia is characterized by altered resting-state functional
connectivity. Most previous studies have focused on changes in connectivity strengths;
however, the alterations in connectivity density in schizophrenia remain largely unknown.
Here, we aimed to investigate changes in resting-state functional connectivity density
(rsFCD) in schizophrenia.
Methods: A total of 95 schizophrenia patients and 93 sex- and age-matched healthy
controls (HCs) underwent resting-state functional MRI examinations. The rsFCD, which
reflects the total number of functional connections between a given brain voxel and all
other voxels in the entire brain, was calculated for each voxel of each subject. Voxel-based
comparisons were performed to identify brain regions with significant rsFCD differences
between patients and controls (P < 0.05, corrected).
Results: Compared with HCs, patients with schizophrenia showed significantly increased
rsFCD in the bilateral striatum and hippocampus and significantly decreased rsFCD in the
bilateral sensorimotor cortices and right occipital cortex. However, the rsFCD values of
these brain regions were not correlated with antipsychotic dosage, illness duration, or
clinical symptom severity.
Conclusions: The striatal and hippocampal regions and parietal-occipital regions exhibited
completely different changes in rsFCD in schizophrenia, which roughly correspond
to dopamine activity in these regions in schizophrenia. These findings support the
connectivity disorder hypothesis of schizophrenia and increase our understanding of the
neural mechanisms of schizophrenia.
Keywords: schizophrenia, resting state, functional magnetic resonance imaging, functional connectivity density,
functional connectivity strength
INTRODUCTION
Schizophrenia is a devastating psychiatric disease that is charac-
terized by hallucinations, delusions, loss of initiative, and cogni-
tive deficits (van Os and Kapur, 2009; Gustavsson et al., 2011).
Although there is no accepted theory accounting for schizophre-
nia (Rubinov and Bullmore, 2013), connectivity disturbance has
been considered a hallmark of schizophrenia. Using diffusion ten-
sor imaging (DTI), extensive anatomical connection impairments
have been found in schizophrenia (van den Heuvel et al., 2010,
2013; Wang et al., 2012). Using functional magnetic resonance
imaging (fMRI), resting-state functional connectivity strength
(rsFCS) has been proposed to explore intrinsic association
between two brain regions. It measures temporal correlations of
spontaneous fluctuations in brain activity between different pairs
of brain areas (Biswal et al., 1995). rsFCS may reflect intrinsic
functional organization of the brain. Schizophrenia patients have
shown rsFCS alterations in multiple specific brain regions and
networks (Karbasforoushan and Woodward, 2012; Woodward
et al., 2012; Moran et al., 2013; Orliac et al., 2013; Shinn et al.,
2013; Argyelan et al., 2014; Klingner et al., 2014; Kraguljac et al.,
2014; Liu et al., 2014). For example, schizophrenia patients have
decreased inter-regional rsFCS between the amygdala and frontal
lobe (Liu et al., 2014) and between the hippocampus and pari-
etal lobe (Kraguljac et al., 2014). They also exhibit decreased
intra-network rsFCS in the default-mode network (DMN) and
salience network (SN) (Orliac et al., 2013). The patients also
have decreased inter-network rsFCS between the SN and central
executive network (CEN) and DMN (Moran et al., 2013). Both
the decreased (Woodward et al., 2012) and increased (Klingner
et al., 2014) prefrontal-thalamic rsFCS have been reported in
schizophrenia, although the increased somatosensory-thalamic
rsFCS is rather consistent (Woodward et al., 2012; Klingner
et al., 2014). However, most previous studies investigating rsFCS
abnormalities in schizophrenia used hypothesis-driven meth-
ods based on a priori selection of a region of interest (ROI)
(Woodward et al., 2012; Shinn et al., 2013; Klingner et al.,
2014; Kraguljac et al., 2014; Liu et al., 2014), which cannot pro-
vide a full picture of the brain rsFCS changes in schizophrenia.
Thus, several studies have investigated rsFCS alterations across
the entire brain in schizophrenia using a multiple ROI-based
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method (Liang et al., 2006; Venkataraman et al., 2012). Liang et al.
found decreased rsFCS between many pairs of brain regions in
schizophrenia (Liang et al., 2006). However, Venkataraman et al.
reported that patients with schizophrenia exhibited co-existing
patterns of increased rsFCS between parietal and frontal regions,
and decreased rsFCS between parietal and temporal regions and
between the temporal cortices bilaterally (Venkataraman et al.,
2012). Almost all previous studies have focused on rsFCS changes
in schizophrenia; however, connection number changes of each
voxel across the entire brain in schizophrenia are still unclear.
Recently, resting-state functional connectivity density (rsFCD)
has been developed to measure the number of resting-state func-
tional connections of a given voxel with all other voxels in the
entire brain (Tomasi and Volkow, 2010, 2011a,b). rsFCD map-
ping is an ultra-fast voxel-wise data-driven method for com-
puting rsFCD with high spatial resolution (3-mm isotropic)
(Tomasi and Volkow, 2010, 2011a,b) and has been used to identify
age-related connectivity changes, connectivity differences across
genetic backgrounds, and connectivity alterations in some disor-
ders (Tomasi and Volkow, 2012a,b, 2014; Tian et al., 2013). rsFCS
measures connectivity strength between two voxels or regions
or networks, which reflects a one-to-one relationship. However,
rsFCD reflects a one-to-many relationship. A greater rsFCD value
for a particular voxel indicates that this voxel is functionally con-
nected to a greater number of other brain voxels and suggests that
this voxel plays a more important role in the information pro-
cessing of the brain than those voxels with lower rsFCD values.
Thus, rsFCS and rsFCD reflect different connectivity proper-
ties. Investigating rsFCD changes in schizophrenia may provide
extra information (change in importance of a voxel in informa-
tion processing) that cannot be obtained from an rsFCS analysis.
This information may facilitate our understanding of the neural
mechanisms of schizophrenia from a new perspective.
In the present study, we compared rsFCD differences between
95 schizophrenia patients and 93 healthy controls (HCs) to
identify brain regions with altered rsFCD in schizophrenia.
MATERIALS AND METHODS
SUBJECTS
A total of 200 right-handed individuals were enrolled in the
present study, including 98 schizophrenia patients and 102HCs.
The diagnoses and illness durations of schizophrenia were deter-
mined by the consensus of two experienced clinical psychiatrists
using the Structured Interview for DSM-IV Axis I Disorders. All
HCs were screened using the non-patient edition of the SCID to
confirm a lifetime absence of psychiatric illnesses. In addition, all
of the HCs were interviewed to exclude individuals with a known
history of psychiatric illness in first-degree relatives. Exclusion
criteria for all subjects were a history of head trauma with con-
sciousness disturbances lasting more than 5min, a history of drug
or alcohol abuse, pregnancy, and any physical illness such as car-
diovascular disease or neurological disorders, as diagnosed by
an interview and medical records review. A professional radiol-
ogist assessed image quality slice-by-slice, and three patients and
9 HCs with poor image quality were excluded. Consequently, 95
schizophrenia patients and 93 HCs were included in the statisti-
cal analysis. Clinical symptoms of psychosis were quantified using
the Positive and Negative Syndrome Scale (PANSS). The antipsy-
chotic dosages are reported (Table 1) as the chlorpromazine
equivalents calculated based on clinically equivalent dosing esti-
mates (Gardner et al., 2010). For each schizophrenia patient,
the chlorpromazine equivalent was estimated according to the
antipsychotic drugs and dosages used in the latest week before
the MRI scan. The Medical Research Ethics Committee of Tianjin
Medical University General Hospital approved this study. After a
complete description of the study, written informed consent was
obtained from each subject.
MRI DATA ACQUISITION
MRI data were acquired using a 3.0-Tesla MR system (Discovery
MR750, General Electric, Milwaukee, WI, USA). Tight but com-
fortable foam padding was used to minimize head motion, and
earplugs were used to reduce scanner noise. Sagittal 3D T1-
weighted images were acquired using a brain volume sequence
with the following parameters: repetition time (TR) = 8.2ms;
echo time (TE) = 3.2ms; inversion time (TI) = 450ms;
flip angle (FA) = 12◦; field of view (FOV) = 256 × 256mm;
matrix = 256 × 256; slice thickness = 1mm, no gap; and 188
sagittal slices. Resting-state fMRI data were acquired using a
gradient-echo single-short echo planar imaging sequence with
the following parameters: TR/TE = 2000/45ms; FOV = 220 ×
220mm; matrix = 64 × 64; FA = 90◦; slice thickness = 4mm;
gap = 0.5mm; 32 interleaved transverse slices; and 180 volumes.
All subjects were instructed to keep their eyes closed, relax, move
as little as possible, think of nothing in particular, and not fall
asleep during the fMRI scans.
fMRI DATA PREPROCESSING
Resting-state fMRI data were preprocessed using SPM8 (http://
www.fil.ion.ucl.ac.uk/spm). The first 10 volumes for each subject
were discarded to allow the signal to reach equilibrium and the
participants to adapt to the scanning noise. The remaining vol-
umes were corrected for the acquisition time delay between slices.
Then, realignment was performed to correct the motion between
time points. All subjects’ fMRI data were within the defined
Table 1 | Demographic and clinical characteristics.
Characteristics Schizophrenia Comparison P-value
patients subjects
Number of subjects 95 93
Age (years) 33.6 (7.8) 33.0 (10.2) 0.633
Sex (female/male) 41/54 48/45 0.246
Antipsychotic dosage (mg/d)
(chlorpromazine equivalents)
446.5 (341.6)
Duration of illness (months) 121.4 (92.8)
PANSS
Positive score 17.1 (7.9) –
Negative score 20.3 (9.1) –
General score 34.1 (10.8) –
Total score 71.5 (23.2) –
Data are shown as the means (SD). Abbreviations: PANSS, The Positive and
Negative Syndrome Scale.
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motion thresholds (i.e., translational or rotational motion param-
eters less than 2mm or 2◦). We also calculated frame-wise dis-
placement (FD), which indexes the volume-to-volume changes
in head position. There were no significant group differences in
FD (t = 0.56, P = 0.58) between patients (0.117 ± 0.007) and
controls (0.113 ± 0.006). Several nuisance covariates (six motion
parameters, their first time derivations, and average BOLD sig-
nals of the ventricular and white matter) were regressed out from
the data. Recent studies have reported that the signal spike caused
by head motion significantly contaminated the final resting-state
fMRI results even after regressing out the linear motion parame-
ters (Power et al., 2012). Therefore, we further regressed out spike
volumes when the FD of the specific volume exceeded 0.5. The
datasets were then band-pass filtered in a frequency range of 0.01–
0.08Hz. In the normalization step, individual structural images
were linearly co-registered with the mean functional image; the
structural images were then linearly co-registered to MNI space.
Finally, each filtered functional volume was spatially normalized
to MNI space using co-registration parameters and resampled
into a 3-mm cubic voxel.
rsFCD CALCULATION
The rsFCD of each voxel was calculated using an in-house script
that was written in the Linux platform according to the method
described by Tomasi and Volkow (2010, 2011a,b). Pearson’s linear
correlation evaluated the strength of the functional connectiv-
ity between voxels. Two voxels with a correlation coefficient of
R > 0.6 were considered significantly connected. This threshold
was proposed to be the optimal threshold for calculating rsFCD
in a previous study (Tomasi and Volkow, 2010). The rsFCD cal-
culation was restricted to a cerebral gray matter (GM) mask. The
rsFCD at a given voxel x0 was computed as the total number of
functional connections, k(x0), between x0 and all other voxels.
This calculation was repeated for all x0 voxels in the brain. The
grand mean scaling of rsFCD was obtained by dividing by the
mean value of all brain voxels to increase the normality of the dis-
tribution. Finally, the rsFCD maps were spatially smoothed using
a 6 × 6 × 6mm full-width at half maximum (FWHM) Gaussian
kernel. To explore the effects of the selection of correlation thresh-
olds on our rsFCD analysis, rsFCD maps were also calculated
based on two additional correlation thresholds (R > 0.2 and 0.4).
GRAY MATTER VOLUME CALCULATION
The gray matter volume (GMV) of each voxel was calculated
using voxel-based morphometry (VBM), as implemented in
the VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm.html).
Structural MR images were segmented into GM, white matter and
cerebrospinal fluid using the standard segmentation model. After
an initial affine registration of the GM concentration map into
Montreal Neurological Institute (MNI) space, GM concentration
images were nonlinearly warped using diffeomorphic anatomi-
cal registration through the exponentiated Lie algebra (DARTEL)
technique, and the results were resampled to a voxel size of
3 × 3 × 3mm. The relative GMV of each voxel was obtained
by multiplying the GM concentration map by the non-linear
determinants that were derived from the spatial normalization
step. Finally, the GMV images were smoothed using a Gaussian
kernel of 6 × 6 × 6mm FWHM. After spatial preprocessing, the
smoothed GMV maps were used for statistical analyses.
STATISTICAL ANALYSIS
Group differences in rsFCD were compared in a voxel-wise man-
ner using a general linear model with age and sex as nuisance
variables. A permutation-based inference tool for nonparamet-
ric statistics in FMRIB’s diffusion toolbox (FSL 4.0, http://www.
fmrib.ox.ac.uk/fsl) was used to perform this analysis. The number
of permutations was set to 5000, and the significance threshold
was set at P < 0.05 after correcting for family-wise error (FWE)
using the threshold-free cluster enhancement (TFCE) option in
FSL. To exclude the possible effects of GMV on rsFCD changes,
we repeated the group comparisons with the GMV as an addi-
tional covariate of no interest at the voxel-wise level. Moreover,
the same statistical steps were applied to rsFCD at the thresholds
of R > 0.2 and 0.4.
The mean rsFCD of each cluster with significant group dif-
ferences was extracted for each subject. The partial correlation
coefficient was used to test the association between rsFCD and the
clinical variables, which included antipsychotic agent dosages of
chlorpromazine equivalents, illness duration and PANSS scores.
Age and gender effects were controlled, andmultiple comparisons
were corrected using the Bonferroni method (P < 0.05).
In addition, correlation analyses between rsFCD and clinical
variables were performed in a voxel-wise manner in the whole
brain. A linear regression model was used to perform correlation
analyses with age and gender as covariates of no interest. Multiple
comparisons were corrected using a FWE method (P < 0.05). To
clarify the relationship between rsFCD and psychosis, we further
divided the schizophrenia patients into patients with current psy-
chotic symptoms (n = 57) and those without current psychotic
symptoms (n = 38) and compared the rsFCDdifferences between
the subgroups (P < 0.05, FWE correction).
RESULTS
SUBJECT DEMOGRAPHICS AND CLINICAL CHARACTERISTICS
The demographic and clinical characteristics of the subjects are
summarized in Table 1. There were no significant group differ-
ences in sex (χ2 = 1.35, P = 0.25) or age (t = 0.48, P = 0.63).
Eighty-seven patients received medications during the MRI
examinations, and the remaining 8 patients had never received
anymedications. Themean dosage of antipsychotic agents (chlor-
promazine equivalents) was 446.5 ± 341.6mg/d for schizophre-
nia patients. The mean duration of illness was 121.4 ± 92.8
months. The mean scores of PANSS positive sub-scale, negative
sub-scale and general psychopathology sub-scale were 17.1 ± 7.9,
20.3 ± 9.1, and 34.1 ± 10.8.
rsFCD DIFFERENCES BETWEEN SCHIZOPHRENIA PATIENTS AND
HEALTHY CONTROLS
Without GMV correction, compared with HCs, schizophrenia
patients exhibited increased rsFCD in the bilateral sub-cortical
regions (including putamen, pallidum, left caudate body) and
hippocampi and decreased rsFCD in the bilateral postcentral gyri,
right inferior temporal gyrus and occipital cortex (Figure 1A
and Table 2). After correction for GMV, the distribution of
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FIGURE 1 | Brain regions with significant differences in rsFCD
(P < 0.05, FWE corrected) between schizophrenia patients and healthy
comparison subjects without (A) and with (B) correction for GMV. The
warm color represents increased rsFCD and the cold color denotes
decreased rsFCD in patients with schizophrenia. Overlap between
significant rsFCD difference maps without and with GMV correction (C).
Red denotes increased rsFCD in schizophrenia without GMV correction;
yellow represents increased rsFCD both without and with GMV correction.
Blue and green denote decreased rsFCD without and with GMV correction,
respectively; cyan represents decreased rsFCD both without and with GMV
correction.
brain regions with significant differences in rsFCD was similar
to that observed without GMV correction; however, the spatial
extent was much smaller in the striatal and hippocampal regions
(Figure 1B and Table 3). Significant rsFCD difference maps with
and without GMV correction are overlapped in Figure 1C. In
addition, brain regions with significant intergroup differences
in rsFCD at the correlation thresholds of R > 0.2 and 0.4 are
shown in Supplementary Figures S1, S2. Almost all of the sig-
nificant brain regions at the threshold of R > 0.6 were included
in the maps using thresholds of R > 0.2 and 0.4; however, the
spatial extent of significant brain regions was much larger at
the thresholds of R > 0.2 and 0.4 than that at the threshold of
R > 0.6.
THE ASSOCIATION BETWEEN rsFCD AND CLINICAL VARIABLES
In brain areas demonstrating group differences in rsFCD with
correction for GMV, we did not find any statistical correlations
between rsFCD and antipsychotic dosages of chlorpromazine
equivalents, illness duration, and all PANSS scores (positive, neg-
ative, general psychopathology scores) (Supplementary Table S1).
Table 2 | rsFCD changes in schizophrenia patients relative to healthy
controls without GMV correction.
Brain Brodmann Cluster size Peak Coordinates in
regions areas (voxels) t-values MNI (x, y, z)
SCHIZOPHRENIA PATIENTS > HEALTHY CONTROLS
Left putamen,
pallidum
– 225 4.16 −12, 3, −6
Right putamen,
pallidum
– 194 4.27 12, 9, −9
Left caudate body – 38 2.99 −9,−3, 15
Left hippocampus 36, 35 270 3.81 −27, −36, −3
Right hippocampus 35 237 3.39 27, −30, −6
SCHIZOPHRENIA PATIENTS < HEALTHY CONTROLS
Right occipital lobe 18 178 −4.80 27, −90, −3
Left postcentral gyrus 2, 3 241 −4.60 −57, −12, 33
Right postcentral
gyrus
2, 3 111 −4.35 48, −24, 42
Right inferior
temporal gyrus
37 25 −4.83 42, −66, −6
Abbreviations: rsFCD, resting-state functional connectivity density; MNI,
Montreal Neurological Institute.
Table 3 | rsFCD changes in schizophrenia patients relative to healthy
controls with GMV correction.
Brain Brodmann Cluster size Peak Coordinates in
regions areas (voxels) t-values MNI (x, y, z)
SCHIZOPHRENIA PATIENTS > HEALTHY CONTROLS
Left putamen,
pallidum
– 24 4.11 −12, 3, −6
Right putamen,
pallidum
– 70 4.09 15, 3, −3
Left hippocampus – 20 3.80 −27, −36, −3
SCHIZOPHRENIA PATIENTS < HEALTHY CONTROLS
Right occipital lobe 18 107 −4.81 27, −90, −3
Left postcentral gyrus 2, 3 237 −4.67 −54, −12, 36
Right postcentral
gyrus
2, 3 63 −4.01 48, −24, 45
Abbreviations: rsFCD, resting-state functional connectivity density; MNI,
Montreal Neurological Institute.
Additionally, no brain regions exhibited significant correlations
between rsFCD and clinical variables in the voxel-based analyses
(P < 0.05, FWE corrected). We did not observe any significant
differences in rsFCD between patients with and without current
psychotic symptoms (P < 0.05, FWE corrected).
DISCUSSION
In this study, we used a data-driven voxel-based method to com-
pare rsFCD differences between schizophrenia patients and HCs.
We found that schizophrenia patients exhibited increased rsFCD
in the striatum and hippocampus and decreased rsFCD in the
postcentral gyri and occipital cortex compared with HCs. The
rsFCD changes in these regions reflect an alteration of total num-
ber of functional connections between these regions and all other
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voxels in the whole brain, representing an alteration of commu-
nication capacity and functional brain dynamics in these regions.
Thus, our findings provide new evidence for the hypothesis that
schizophrenia is a disorder of connectivity abnormalities from the
perspective of functional connectivity density.
INCREASED FCD IN SCHIZOPHRENIA
In the present study, we found that schizophrenia patients had
increased rsFCD in the striatum and hippocampus. The stria-
tum and hippocampus are central components of the brain in the
generation of psychosis and other symptom states in schizophre-
nia (Davis et al., 1991; Epstein et al., 1999; Howes and Kapur,
2009; Perez-Costas et al., 2010; Grace, 2012). Previous studies
have demonstrated early striatal hypertrophy in first-episode psy-
chosis (Chua et al., 2009) and significant correlations between
GM density in the hippocampus and early psychotic symp-
toms in adolescents at risk of psychosis (Spencer et al., 2007).
Several studies have suggested that the hyper-spontaneous neural
activity in the striatum and hippocampus is a pathological fea-
ture of schizophrenia. For example, increased regional cerebral
blood flow (rCBF) and amplitude of low frequency fluctuation
(ALFF) in the striatum and hippocampus have been frequently
reported in schizophrenia (Malaspina et al., 2004; Hoptman et al.,
2010; Scheef et al., 2010; Pinkham et al., 2011; Liu et al., 2012;
Turner et al., 2013).Moreover, previous studies have also reported
increased rsFCS of the striatum and hippocampus with other
parts of the brain (Salvador et al., 2010; Hoffman et al., 2011).
However, Koch et al. found decreased striatal functional con-
nectivity using psychophysiological interactions (PPI), which was
closely linked to GMV changes of the striatum (Koch et al., 2014).
Different methodologies (PPI vs. FCD) and experimental designs
(task-evoked vs. resting-state) may account for the different find-
ings between that study and ours. Although several previous
studies suggested that increased functional activity and connec-
tivity in these regions may be an effect of antipsychotic drugs,
our non-significant correlations between aberrant rsFCD and
antipsychotic dosages do not support this hypothesis. Our find-
ings of increased rsFCD in the striatum and hippocampus may
support the connectivity disorder hypothesis of schizophrenia
from a new perspective of the number of functional connectivity.
After correcting for GMV, the spatial extent of the striatal and
hippocampal regions with significant rsFCD differences between
groups was much smaller than without GMV correction. This
finding indicates that rsFCD increases in the striatal and hip-
pocampal regions are partially related to GM atrophy. To clarify
the specific relationship between rsFCD and GMV, we performed
a correlation analysis in patients and controls, respectively.We did
not find any significant correlations (Supplementary Table S2).
These findings suggest that the relationship between GMV and
rsFCD changes in schizophrenia is rather complex. In future stud-
ies on schizophrenia, the GMV effect on the functional changes
(such as the rsFCD) should be considered.
DECREASED FCD IN SCHIZOPHRENIA
We also found decreased rsFCD in the cortical regions involved
in processing of sensorimotor and visual information; this effect
is independent of GMV changes in these regions. These findings
are consistent with a previous study that reported decreased local
FCD in the sensorimotor cortex in schizophrenia (Tomasi and
Volkow, 2014). The sensorimotor and visual areas also showed
decreased rCBF (Pinkham et al., 2011), ALFF (Hoptman et al.,
2010; Turner et al., 2013) and regional homogeneity (ReHo) (Liu
et al., 2006; Yu et al., 2013) in schizophrenia. Hypoconnectivity
of the visual and sensormotor networks has also been reported
in schizophrenia (Collin et al., 2011; Tang et al., 2012; Calderone
et al., 2013; Damaraju et al., 2014). Abnormal activity or connec-
tivity of the visual cortex may be associated with deficits in visual
processing and object-recognition in schizophrenia (Onitsuka
et al., 2007; Wynn et al., 2008). Similarly, abnormal activity or
connectivity of the sensorimotor cortex may be related to neuro-
logical soft signs that cause neurological abnormalities in sensory
integration, motor regulation, and sequencing complex motor
acts in schizophrenia patients (Schmauss et al., 1993). Combined
with these previous studies, our findings further support the
functional disconnectivity hypothesis of schizophrenia from the
perspective of connectivity density.
ASSOCIATION BETWEEN FCD CHANGES AND THE DOPAMINE
HYPOTHESIS OF SCHIZOPHRENIA
A previous imaging genetics study revealed that FCD can be
modulated by the presumed dopamine signaling in healthy sub-
jects, and the modulation pattern is different in different regions
(Tian et al., 2013). This study found an association between
FCD and dopamine activity. According to the dopamine hypoth-
esis of schizophrenia, hyperdopaninergia in the striatum, and
hypodopaminergia in the cortical regions, especially the pre-
frontal cortex, have been conceived as an important pathological
feature of schizophrenia (Howes and Kapur, 2009). Dopamine
neuron responsivity is shown to be modulated by the hippocam-
pus, which exhibits hyperactivity in schizophrenia (Grace, 2012).
Therefore, hyperdopaninergia in the striatum may reflect an
overly responsive state of the dopamine system that is driven
by hyperactivity in the hippocampus. This theoretical hypothe-
sis may explain our findings of increased rsFCD in the striatum
and hippocampus in schizophrenia. In contrast to the dominant
dopamine receptor D2 in the striatum, the dominant dopamine
receptor is D1 in the cerebral cortex. D1 dysfunction in the
prefrontal cortex has been linked to cognitive impairment and
negative symptoms in schizophrenia (Abi-Dargham and Moore,
2003; Goldman-Rakic et al., 2004; Laruelle, 2014). The distribu-
tion differences in dopamine receptors between the striatum and
cortex may be an explanation for the completely different rsFCD
changes in these two kinds of brain regions in schizophrenia.
However, most previous studies focused on dopamine activity in
the prefrontal cortex; whether the influence of this activity can
be applied to the sensory and motor areas need to be further
determined. However, there is a lack of direct evidence for an
association between FCD changes and dopamine activity; thus,
future studies are needed to clarify this potential association.
In this present study, we did not find a correlation between
aberrant rsFCD and antipsychotic dose, illness duration, and
symptom severity. These results suggest that aberrant rsFCD
may be an independent trait characteristic of schizophrenia,
which means that all schizophrenia patients have aberrant rsFCD,
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regardless of symptom severity. This is not surprising, given that
many studies have shown that illness duration, symptom severity,
and antipsychotic dose are not linearly related to brain functional
activity disturbances. Furthermore, we did not observe any dif-
ferences in rsFCD between patients with and without current
psychotic symptoms. BOLD signal alterations may better track
schizophrenia, regardless of the presence or absence of psychosis,
rather than psychosis severity or duration and are not linearly
related to antipsychotic dose (Woodward et al., 2012; Ren et al.,
2013). However, we cannot rule out the possibility that either a
lack of statistical power or a lack of data assessing the appropriate
dependent clinical variables may account for non-significant cor-
relations between rsFCD and demographic and clinical variables
in our study. Therefore, in future studies, appropriate statisti-
cal methods and detailed clinical variables may contribute to the
solution of this problem.
CONCLUSION
Our study found that increased rsFCD in the striatal and
hippocampal regions and decreased rsFCD in the sensorimo-
tor regions are pathological features of schizophrenia, which
may support the hypothesis that schizophrenia is a connec-
tivity disorder from the perspective of functional connectivity
density. The similar spatial distribution and abnormal patterns
between brain regions with rsFCD alterations and those with
dopamine alterations are interesting findings and deserve further
investigations.
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